Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inhibikase Therapeutics
Biotech
Inhibikase clears another clinical hold, preps new phase 2 trial
Inhibikase has had a second clinical hold lifted by the FDA, allowing the company to prep phase 2 plans of its treatment for multiple system atrophy.
Max Bayer
Mar 8, 2023 10:18am
Inhibikase, FDA agree on terms to lift Parkinson's drug hold
Jan 25, 2023 11:24am
Inhibikase stock sinks on FDA clinical hold of Parkinson's drug
Nov 7, 2022 9:25am
Inhibikase Therapeutics slahes deal size ahead of IPO
Nov 4, 2020 8:00am
